Cell proliferation in serial biopsies through human malignant brain tumours: Measurement using Ki67 antibody labelling

References

• Trott K-R, Kummermehr J. What is known about tumour proliferation rates to choose between accelerated fractionation or hyperfractionation?. Radiother Oncol 1985; 3: 1–9
   PubMed Web of Science ®Google Scholar
• Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 12–20
   Google Scholar
• Gerdes J, Lemke H, Baish H, Wacker H-W, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki67. J Immunol 1984; 133: 1710–5
   PubMed Web of Science ®Google Scholar
• Verheijen R, Kuijpers H JH, Schlingemann R O, et al. Ki67 detects a nuclear matrix-associated proliferation-related antigen. 1. Spatial distribution and intracellular localisation during interphase. J Cell Sci 1989; 92: 123
   PubMed Web of Science ®Google Scholar
• McGurrin J F, Doria M I, Dawson P J, Karrison T, Stein H O, Franklin W A. Assessment of tumour cell kinetics by immunohistochemistry in carcinoma of breast. Cancer 1986; 59: 1744–50
   Google Scholar
• Brown D C, Cole D, Gatter K C, Mason D Y. Carcinoma of the cervix uteri: An assessment of tumour proliferation using the monoclonal antibody Ki67. Br J Cancer 1988; 57(2)178–81
   Google Scholar
• Gatter K C, Dunnill M S, Gerdes J, Stein H, Mason D Y. New approach to assessing lung tumours in man. J Clin Pathol 1986; 39: 590–3
   PubMed Web of Science ®Google Scholar
• Hall P A, Richards M A, Gregory W M, Ardenne D AJ, Lister J A, Stanfield A G. The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol 1988; 154: 223–35
   PubMed Web of Science ®Google Scholar
• Bush C, Price P, Norton J, Parkins C S, Bailey M J, Boyd J, Jones C R, Hern A' RP, Horwich A. Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importance. Br. J Cancer April, 1991, accepted
   Google Scholar
• Zuber P, Hamou M-F, de Tribolet N. Identification of proliferating cells in human gliomas using the monoclonal antibody Ki67. Neurosurgery 1988; 22: 364–8
   PubMed Web of Science ®Google Scholar
• Burger P C, Shabita T, Kleihues P. The use of the monoclonal antibody Ki67 in the identification of proliferating cells: Application to surgical neuropatho-logy. Am J Surg Pathol 1986; 10(9)611–7
   Google Scholar
• Ostertag C B, Volk B, Shabita T, Burger P, Kleihues P. The monoclonal antibody Ki67 as a marker for proliferating cells in stereotactic biopsies of brain tumours. Acta Neurochir (Wien) 1987; 89: 117–21
   Google Scholar
• Shabita T, Burger P C. The use of the monoclonal antibody Ki67 in determination of the growth fraction in pediatric brain tumours. Child's Nerv Syst 1987; 3: 364–7
   Google Scholar
• Patsouris E, Stocker U, Kallmeyer V, Keiditsch E, Mehrain P, Stavrou D. Relationship between Ki67 positive cells, growth rate and histological type of human intracranial tumours. Anticancer Res 1988; 8: 537–44
   PubMed Web of Science ®Google Scholar
• Greenberg H S, Chandler W F, Diaz R F, et al. Intra-arterial bromodeoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas. J Neurosurg 1988; 69: 500–5
   PubMed Web of Science ®Google Scholar
• Gratzner H G. Monoclonal antibody to 5-Bromo-and 5-Iodo-deoxyuridine: A new reagent for detection of DNA replication. Science 1982; 218: 474–5
   PubMed Web of Science ®Google Scholar
• Wilson G D, McNally N J, Dische S, et al. Measurement of cell kinetics in human tumours using in vivo bromodeoxyuridine incorporation and flow cytometry. BrJ Cancer 1988; 58: 423–31
   PubMed Web of Science ®Google Scholar
• Danova M, Riccardi A, Gaetini P, et al. Cell kinetics of human brain tumours: In vivo study with bromodeoxyuridine and flow cytometry. Eur J Cancer Clin Oncol 1988; 24: 873–80
   PubMedGoogle Scholar
• Hoshino T, Nagashima T N, Murovic J, Levin E M, Levin V A, Rupp S M. Cell kinetic studies of in situ human brain tumours with bromodeoxyuridine. Cytometry 1985; 6: 627–32
   PubMedGoogle Scholar
• Nishizaki T, Orita T, Saiki M, Furutani Y, Aoki H. Cell kinetic studies of human brain tumours by in vitro labelling using anti-BUdR monoclonal antibody. J Neurosurg 1988; 69: 371–4
   Google Scholar
• Franzini A, Ferraresi S, Giorgi C, Costa A, Allegranza A, Broggi G. Cell kinetic investigations in brain tumours studied by serial stereotactic biopsy. J Neu-rooncol 1989; 7: 373–9
   Google Scholar
• Thomas D GT, Gill S S, Wilson C B, Darling J L, Parkins C S. Use of relocatable stereotactic frame to integrate positron emission tomography and computed tomography images: application in human malignant brain tumours. Stereotact Farct Neurosurg 1990; 54&55: 388–92
   Google Scholar
• Gill S S, Warrington A P, Thomas D GT, Brada M. A relocatable frame for stereotactic external beam radiotherapy. Int J Radiat Oncol Biol Phys 1991, in press
   Google Scholar
• Deckert M, Reifenberger G, Wechsler W. Determination of the proliferative potential of human brain tumours using the monoclonal antibody Ki67. J Cancer Res Clin Oncol 1989; 115: 179–88
   Google Scholar
• Price P, Bush C, Parkins C S, Imrie P, Ormerod M G, Steel G G. Ki67 in the assessment of tumour growth rate: A study on xenografts. Int J Radiat Biol 1989; 56: 797–800
   PubMed Web of Science ®Google Scholar
• Parkins C S, Begg A C, Bush C, et al. In vivo bromodeoxyuridine labelling in human tumour xenografts. Int J Radiat Biol 1989; 56: 787–91
   PubMed Web of Science ®Google Scholar
• Parkins C S, Bush C, Price P, Steel G G. Immunohisto-chemical measurement of cell proliferation in human tumour xenografts using bromodeoxyuridine and Ki67 antibody labelling. Cell Prolif 1991; 24, in press
   Google Scholar
• Silvestrini R, Costa A, Veneroni S, Delbino G, Perisici P. Comparative analysis of different approaches to investigate cell kinetics. Cell Tissue Kinet 1988; 21: 123–31
   PubMedGoogle Scholar
• Begg A C, McNally N J, Schrieve D C, Karcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 1985; 6: 620–6
   PubMedGoogle Scholar
• Jones T, Beaney R, Brady F, Lammertsma A, Rhodes C, Wilson C. Imaging with special emphasis on positron emission tomography scanning for functional measurement. In: The scientific basis of modern radiotherapy. British Institute of Radiology. Report 1989; 19: 127–31
   Google Scholar